×
About 24,868 results

ALLMedicine™ Menopause Center

Research & Reviews  6,928 results

An online survey of perimenopausal women to determine their attitudes and knowledge of ...
https://doi.org/10.1177/17455057221106890
Women's Health (London, England); Harper JC, Phillips S et. al.

Jun 28th, 2022 - Women are not usually taught about the menopause formally, and many general practitioners have relatively little training. The aim of this study was to explore perimenopausal women's attitudes and knowledge of the menopause. An online survey was d...

Depression and anxiety in colorectal cancer patients: TIES TO PAIN, FATIGUE, AND INFLAM...
https://doi.org/10.1002/pon.5986
Psycho-oncology Renna ME, Shrout MR et. al.

Jun 26th, 2022 - Colorectal cancer poses a significant threat to both psychological and physical health. This study examined relationships between anxiety and depressive symptoms with pain, fatigue, and inflammation among colorectal patients. Colorectal cancer pat...

Sexual Function and Mood Disorders Among Menopausal Women: A Systematic Scoping Review.
https://doi.org/10.1016/j.jsxm.2022.03.614
The Journal of Sexual Medicine; Rahmani A, Afsharnia E et. al.

Jun 26th, 2022 - Changes in sex hormones during menopause may have detrimental effects on a woman's sexual function and cause mood disorders. The treatment of both conditions is a challenge in gynecology. To review the published literature on sexual function and m...

Associations of resting and peak fat oxidation with sex hormone profile and blood gluco...
https://doi.org/10.1016/j.numecd.2022.06.001
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Karppinen JE, Juppi HK et. al.

Jun 26th, 2022 - Menopause may reduce fat oxidation. We investigated whether sex hormone profile explains resting fat oxidation (RFO) or peak fat oxidation (PFO) during incremental cycling in middle-aged women. Secondarily, we studied associations of RFO and PFO w...

Association Between C-Reactive Protein and Relative Handgrip Strength in Postmenopausal...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9211077
Clinical Interventions in Aging; Son DH, Song SA et. al.

Jun 25th, 2022 - Chronic inflammation plays a key role in the pathophysiology of frailty and loss of physical performance, which are closely associated with sarcopenia. In women, the decline in muscle mass and strength is accelerated after menopause. Thus, we exam...

see more →

Guidelines  50 results

Guideline No. 422g: Menopause and Osteoporosis.
https://doi.org/10.1016/j.jogc.2021.09.013
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Khan AA, Alrob HA et. al.

May 17th, 2022 - Provide strategies for improving the care of perimenopausal and postmenopausal women based on the most recent published evidence. Perimenopausal and postmenopausal women. Target population will benefit from the most recent published scientific evi...

Menopause modulates the circulating metabolome: evidence from a prospective cohort study
https://academic.oup.com/eurjpc/advance-article/doi/10.1093/eurjpc/zwac060/6580397?login=false
European Journal of Preventive Cardiology; Karppinen JE, .

May 12th, 2022 - We studied the changes in the circulating metabolome and their relation to the menopausal hormonal shift in 17β-oestradiol and follicle-stimulating hormone levels among women transitioning from perimenopause to early postmenopause.

Guideline No. 425a: Cannabis Use Throughout Women's Lifespans - Part 1: Fertility, Cont...
https://doi.org/10.1016/j.jogc.2022.01.012
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Robert M, Graves LE et. al.

Apr 12th, 2022 - To provide health care providers with the best evidence on cannabis use with respect to women's health. Areas of focus include general patterns of cannabis use as well as safety of use; care for women who use cannabis; stigma; screening, brief int...

Evaluation and Treatment in Urology for Nocturia Caused by Nonurological Mechanisms: Gu...
https://doi.org/10.1016/j.euf.2022.01.007
European Urology Focus; Smith M, Dawson S et. al.

Feb 2nd, 2022 - Patients with nocturia are commonly referred to urology clinics, including many for whom a nonurological medical condition is responsible for their symptoms. The PLanning Appropriate Nocturia Evaluation and Treatment (PLANET) study was established...

Guideline No. 422e: Menopause and Cardiovascular Disease.
https://doi.org/10.1016/j.jogc.2021.09.010
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Abramson BL, Black DR et. al.

Dec 14th, 2021 - Provide strategies for improving the care of perimenopausal and postmenopausal women based on the most recent published evidence. Perimenopausal and postmenopausal women. Target population will benefit from the most recent published scientific evi...

see more →

Drugs  270 results see all →

Clinicaltrials.gov  760 results

Perimenopause-Related Mood and Behavioral Disorders
https://clinicaltrials.gov/ct2/show/NCT00001231

Jun 24th, 2022 - Controversy exists regarding the relevance of changes in gonadal steroids for midlife onset depressions. The purpose of this protocol is to allow for the careful screening of patients and healthy volunteers for participation in research protocols ...

Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease
https://clinicaltrials.gov/ct2/show/NCT00005902

Jun 24th, 2022 - Hemangioblastomas of the cerebellum, brainstem and spinal cord are frequent tumors in patients with von Hippel-Lindau (VHL) disease. Rarely, these lesions also affect the cerebrum. Patients often have multiple lesions, many of which are associated...

Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
https://clinicaltrials.gov/ct2/show/NCT00043472

Jun 24th, 2022 - Background: Annually, more than 25,500 women develop ovarian cancer (OC) and more than 16,000 die of this disease in the United States. Women at high genetic risk of OC have a much higher lifetime risk of developing OC than women in the general po...

Foot Massage for Women With Menopause
https://clinicaltrials.gov/ct2/show/NCT05212376

Jun 24th, 2022 - The population of the study was planned to be composed of menopausal women residing in a village in the north of Turkey. Menopausal women residing in the village were reached from the records of the health unit of the participants. The number of p...

A Study to Learn More About Using Dienogest to Treat Endometriosis in Chinese Participants
https://clinicaltrials.gov/ct2/show/NCT04495855

Jun 23rd, 2022 - Endometriosis is a condition that affects women, usually during their reproductive years. In women with endometriosis, the tissue that lines the uterus starts to grow outside of the uterus. This can cause pain during their periods or during sex, a...

see more →

News  1,846 results

Fast Five Quiz: Menopause
https://www.medscape.com/viewarticle/974118

Jun 24th, 2022 - Menopause is a normal physiologic process diagnosed following the cessation of menses for at least 12 months without a pathological cause. As women grow older, the decline in estrogen levels causes irregular menstrual cycles, until menstruation pe...

Fast Five Quiz: Menopause
https://reference.medscape.com/viewarticle/974118

Jun 24th, 2022 - Menopause is a normal physiologic process diagnosed following the cessation of menses for at least 12 months without a pathological cause. As women grow older, the decline in estrogen levels causes irregular menstrual cycles, until menstruation pe...

Why do we treat menopause as a disease?
https://www.mdedge.com/obgyn/article/255511/menopause/why-do-we-treat-menopause-disease
Marcia Frellick

Jun 17th, 2022 - Menopause gets a bad rap in medical literature and throughout society, say authors of a new analysis. And they argue that the negativity undermines women’s health outlook in the years that should be a natural life transition.

Novel Drug for Menopause Symptoms Passes Phase 3 Test
https://www.medscape.com/viewarticle/975711

Jun 16th, 2022 - Dr Genevieve Neal-Perry A phase 3 trial has associated the neurokinin-3 (NK3)–receptor inhibitor fezolinetant, an oral therapy taken once daily, with substantial control over the symptoms of menopause, according to results of the randomized SKYLIG...

Nonhormonal drug for menopause symptoms passes phase 3 test
https://www.mdedge.com/endocrinology/article/255474/reproductive-endocrinology/nonhormonal-drug-menopause-symptoms-passes
Ted Bosworth

Jun 15th, 2022 - A phase 3 trial has associated the neurokinin-3 (NK3)–receptor inhibitor fezolinetant, an oral therapy taken once daily, with substantial control over the symptoms of menopause, according to results of the randomized SKYLIGHT 2 trial. The nonhormo.

see more →

Patient Education  93 results see all →